(19)
(11) EP 3 191 129 A1

(12)

(43) Date of publication:
19.07.2017 Bulletin 2017/29

(21) Application number: 15840805.4

(22) Date of filing: 10.09.2015
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61P 35/00(2006.01)
A61K 45/06(2006.01)
(86) International application number:
PCT/US2015/049461
(87) International publication number:
WO 2016/040657 (17.03.2016 Gazette 2016/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 10.09.2014 US 201462048770 P

(71) Applicant: The Regents of the University of California
Oakland, CA 94607 (US)

(72) Inventors:
  • MCCORMICK, Frank
    San Francisco, California 94103 (US)
  • WANG, Man-Tzu
    San Francisco, California 94158 (US)

(74) Representative: J A Kemp 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY ANTI-hLIF ANTIBODIES